生物标志物 生物标志物
Ángel Radamés Rábago Monzón1, Juan Fidel Osuna Ramos1, Yair Cruz Narvaez2
1Universidad Autónoma de Sinaloa, Culiacán, SI, Mexico.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究揭示了与2型糖尿病 (T2DM) 和阿尔茨海默病 (AD) 相关的独特肠道微生物群和代谢概况. 这些发现为针对肠道健康的个性化干预铺平了道路,以改善认知功能和患者的结果.
科学领域:
- 微生物组研究的研究.
- 代谢学 代谢学 代谢学
- 神经退行性疾病机制的神经退行性疾病机制
背景情况:
- 2型糖尿病 (T2DM) 和阿尔茨海默病 (AD) 是重要的公共卫生问题.
- 肠道微生物群的变化越来越多地与T2DM和AD的病原发生有关.
- 甲基因组和代谢组分析提供了关于肠道微生物组在代谢调节和痴呆风险中的作用的见解.
研究的目的:
- 调查T2DM和AD患者的独特肠道微生物群和代谢资料.
- 探索肠道失调,代谢变化和认知衰退之间的关系.
- 确定早期诊断的潜在生物标志物和个性化治疗策略的目标.
主要方法:
- 这是一项涉及四组的横截面,观察性,比较性研究:对照组,T2DM组,AD组和AD组与T2DM组.
- 使用生物信息学工具 (MetaHit) 对肠道微生物群多样性和功能进行定量分析.
- 使用磁共振质谱 (MRMS) 和RStudio进行分析的尿液和便样本的代谢分析.
主要成果:
- 在T2DM和AD患者中观察到肠道失调和代谢变化的明显模式,根据年龄而异.
- 在微生物学,代谢学和临床生物标志物之间发现了显著的相关性,特别是与认知衰退相关的生物标志物.
- 特定的便和尿路代谢物被发现与疾病状态有关,包括 (+/-) -乙基基托基克拉佐辛, (-) - 奎布拉卡明, (-) - 贾斯莫诺伊尔-L-异氨酸, (Phenylthio) 乙酸和2,3-Diketo-L-gulonate.
结论:
- 这项研究确定了特定的肠道微生物群和代谢特征与T2DM和AD的认知衰退之间的联系.
- 这些发现为涉及肠道失调的潜在疾病机制提供了洞察力.
- 结果支持开发个性化干预措施,调节微生物群和代谢学特征,以减轻认知障碍.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


